Changes in mental health during opiate replacement therapy: A systematic review

References

• Abbott P.J., Weller S.B., Delaney H.D., Moore B.A. Community reinforcement approach in the treatment of opiate addicts. The American Journal of Drug and Alcohol Abuse 1998; 24: 17–30
   PubMed Web of Science ®Google Scholar
• Bell J., Shanahan M., Mutch C., Rea F., Ryan A., Batey R., Winstock A., et al. A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependence. Addiction 2007; 102: 1899–1907
   PubMed Web of Science ®Google Scholar
• Callaly T., Trauer T., Munro L., Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Australian and New Zealand Journal of Psychiatry 2008; 35: 601–605
   Web of Science ®Google Scholar
• Centre for Reviews and Dissemination. Systematic reviews: CRD’s guidance for undertaking reviews in healthcare. Centre for Reviews and Dissemination, University of York, York 2009
   Google Scholar
• Comiskey C.M., Cox G. Analysis of the impact of treatment setting on outcomes from methadone treatment. Journal of Substance Abuse Treatment 2010; 39: 195–201
   PubMed Web of Science ®Google Scholar
• Darke S., Wodak A., Hall W., Heather N., Ward J. Prevalence and predictors of psychopathy among opioid users. Addiction 1992; 87: 771–776
   Web of Science ®Google Scholar
• Dean A.J., Bell J., Christie M.J., Mattick R.P. Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence. European Psychiatry 2004; 19: 510–513
   PubMed Web of Science ®Google Scholar
• Department of Health. (2007). Misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive.
   Google Scholar
• Eder H., Fischer G., Gombas W., Jagsch R., Stühlinger G., Kasper S. Comparison of buprenorphine and methadone maintenance in opiate addicts. European Addiction Research 1998; 4: 3–7
   PubMed Web of Science ®Google Scholar
• Eder H., Jagsch R., Kraigher D., Primorac A., Ebner N., Fischer G. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 2005; 100: 1101–1109
   PubMed Web of Science ®Google Scholar
• Faggiano F., Vigna-Taglianti F., Versino E., Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, CD002208
   PubMedGoogle Scholar
• Fals-Stewart W., O'Farrell T.J., Birchler G.R. Behavioral couples therapy for male methadone maintenance patients: Effects on drug-using behavior and relationship adjustment. Behavior Therapy 2001; 32: 391–411
   Web of Science ®Google Scholar
• Gossop M., Marsden J., Stewart D., Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: Two-year follow-up results from the national treatment outcome research study. Drug and Alcohol Dependence 2001; 62: 255–264
   PubMed Web of Science ®Google Scholar
• Gossop M., Marsden J., Stewart D., Treacy S. Change and stability of change after treatment of drug misuse: 2-year outcomes from the national treatment outcome research study (UK). Addictive Behaviors 2002; 27: 155–166
   PubMed Web of Science ®Google Scholar
• Gossop M., Marsden J., Stewart D., Kidd T. The national treatment outcome research study (NTORS): 4–5 year follow-up results. Addiction 2003a; 98: 291–303
   PubMed Web of Science ®Google Scholar
• Gossop M., Stewart D., Browne N., Marsden J. Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up. Journal of Substance Abuse Treatment 2003b; 24: 313–321
   PubMed Web of Science ®Google Scholar
• Groß A., Marsch L.A., Badger G.J., Bickel W.K. A comparison between low-magnitude voucher and buprenorphine medication contingencies in promoting abstinence from opioids and cocaine. Experimental and Clinical Psychopharmacology 2006; 14: 148–156
   PubMed Web of Science ®Google Scholar
• Higgins, J.P.T., Altman, D.G., & Sterne J.A.C. (2011). Chapter 8: Assessing the risk of bias in included studies. In J.P.T. Higgins & S. Green (Eds.), Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Retrieved from www.cochrane-handbook.org
   Google Scholar
• Howick, J., et al. (2011). The oxford 2011 levels of evidence. Oxford centre for evidence-based medicine. Retrieved November 1, 2012, from http://www.cebm.net/index.aspx?o=5653
   Google Scholar
• Jaffray M., Matheson C.I., Bond C.M., Lee A.J., McLernon D.J., Johnstone A., Davidson B., et al. Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial. International Journal of Pharmacy Practice 2014; 22: 4–12
   PubMedGoogle Scholar
• Kosten T., Oliveto A., Feingold A., Poling J., Sevarino K., McCance-Katz E., Gonsai K., et al. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug & Alcohol Dependence 2003; 70: 315–325
   PubMed Web of Science ®Google Scholar
• March J.C., Oviedo-Joekes E., Perea-Milla E., Carrasco F. Controlled trial of prescribed heroin in the treatment of opioid addiction. Journal of Substance Abuse Treatment 2006; 31: 203–211
   PubMed Web of Science ®Google Scholar
• Marsch L.A., Bickel W.K., Badger G.J., Jacobs E.A. Buprenorphine treatment for opioid dependence: The relative efficacy of daily, twice and thrice weekly dosing. Drug & Alcohol Dependence 2005; 77: 195–204
   PubMed Web of Science ®Google Scholar
• Mattick R.P., Ali R., White J.M., O'Brien S., Wolk S., Danz C. Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003; 98: 441–452
   PubMed Web of Science ®Google Scholar
• Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, CD002209
   Google Scholar
• Moher D., Hopewell S., Schulz K.F., Montori V., Gøtzsche P.C., Devereaux P.J., Altman D.G., et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology 2010; 63: e1–e37
   PubMed Web of Science ®Google Scholar
• NHS Evidence. (2012). Opioid dependence – Evidence: Levomethadyl acetate hydrochloride. Retrieved October 10, 2012, from http://www.cks.nhs.uk/opioid_dependence/evidence/supporting_evidence/levomethadyl_acetate_hydrochloride
   Google Scholar
• Oviedo-Joekes E., Brissette S., Marsh D.C., Lauzon P., Guh D., Anis A., Schechter M.T. Diacetylmorphine versus methadone for the treatment of opioid addiction. New England Journal of Medicine 2009; 361: 777–786
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes E., March J.C., Romero M., Perea-Milla E. The Andalusian trial on heroin-assisted treatment: A 2 year follow-up. Drug and Alcohol Review 2010; 29: 75–80
   PubMed Web of Science ®Google Scholar
• Pani P.P., Maremmani I., Pirastu R., Tagliamonte A., Gessa G.L. Buprenorphine: A controlled clinical trial in the treatment of opioid dependence* 1. Drug and Alcohol Dependence 2000; 60: 39–50
   PubMed Web of Science ®Google Scholar
• Perneger T.V., Giner F., del Rio M., Mino A. Randomized trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ: British Medical Journal 1998; 317: 13–18
   PubMed Web of Science ®Google Scholar
• Reimer J., Verthein U., Karow A., Schäfer I., Naber D., Haasen C. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction 2011; 106: 1647–1655
   PubMed Web of Science ®Google Scholar
• Robertson J.R., Raab G.M., Bruce M., McKenzie J.S., Storkey H.R., Salter A. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial. Addiction 2006; 101: 1752–1759
   PubMed Web of Science ®Google Scholar
• Schäfer I., Eiroa-Orosa F., Verthein U., Dilg C., Haasen C., Reimer J. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment. Psychopathology 2010; 43: 88–95
   PubMed Web of Science ®Google Scholar
• Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., Hall S.M., et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial. Journal of the American Medical Association 2000; 283: 1303–1310
   PubMed Web of Science ®Google Scholar
• Shaffer H.J., LaSalvia T.A., Stein J.P. Comparing hatha yoga with dynamic group psychotherapy for enhancing methadone maintenance treatment: A randomized clinical trial. Alternative Therapies in Health and Medicine 1997; 3: 57–66
   PubMedGoogle Scholar
• Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid dependence: Self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology 1996; 16: 58–67
   PubMed Web of Science ®Google Scholar
• Strang J., Finch E., Hankinson L., Farrell M., Taylor C., Gossop M. Methadone treatment for opiate addiction: Benefits in the first month. Addiction Research 1997; 5: 71–76
   Web of Science ®Google Scholar
• Strang J., Marsden J., Cummins M., Farrell M., Finch E., Gossop M., Welch S., et al. Randomized trial of supervised injectable versus oral methadone maintenance: Report of feasibility and 6-month outcome. Addiction 2000; 95: 1631–1645
   PubMed Web of Science ®Google Scholar
• Strang J., Metrebian N., Lintzeris N., Potts L., Carnwath T., Mayet S., Forzisi L., et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): A randomised trial. Lancet 2010; 375: 1885–1895
   PubMed Web of Science ®Google Scholar
• Teesson M., Havard A., Fairbairn S., Ross J., Lynskey M., Darke S. Depression among entrants to treatment for heroin dependence in the Australian treatment outcome study (ATOS): Prevalence, correlates and treatment seeking. Drug & Alcohol Dependence 2005; 78: 309–315
   PubMed Web of Science ®Google Scholar
• Teesson M., Havard A., Ross J., Darke S. Outcomes after detoxification for heroin dependence: Findings from the Australian treatment outcome study (ATOS). Drug and Alcohol Review 2006; 25: 241–247
   PubMed Web of Science ®Google Scholar
• Verthein U., Bonorden-Kleij K., Degkwitz P., Dilg C., Köhler W.K., Passie T., Haasen C., et al. Long-term effects of heroin-assisted treatment in germany. Addiction 2008; 103: 960–966
   PubMed Web of Science ®Google Scholar
• Winklbaur B., Jagsch R., Ebner N., Thau K., Fischer G. Quality of life in patients receiving opioid maintenance therapy: A comparative study of slow-release morphine versus methadone treatment. European Addiction Research 2008; 14: 99–105
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2010). Mental health: Strengthening our response (fact sheet no 220). Retrieved March 14, 2013, from http://www.who.int/mediacentre/factsheets/fs220/en/
   Google Scholar